WC
CpG Diagnostics develops precision diagnostic tests to accurately distinguish malignant from benign adnexal masses using a simple blood draw. The company leverages AI-powered analysis of DNA methylation patterns to provide reliable results, moving beyond traditional protein markers. This approach aims to reduce unnecessary surgeries while ensuring high-risk patients receive timely specialist care.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- CpG Diagnostics develops precision diagnostic tests to accurately distinguish malignant from benign adnexal masses using a simple blood draw. The company leverages AI-powered analysis of DNA methylation patterns to provide reliable results, moving beyond traditional protein markers. This approach aims to reduce unnecessary surgeries while ensuring high-risk patients receive timely specialist care.